CERN Corporation

CERN Corporation

Early Stage

Microbicidal Light Treatment for Fungal & Bacterial Vaginosis

Microbicidal Light Treatment for Fungal & Bacterial Vaginosis

Overview

Raised to Date: Raised: $442,702

Total Commitments ($USD)

Platform

StartEngine

Start Date

09/15/2022

Close Date

04/27/2023

Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment

$500

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$0.80

Pre-Money Valuation

$12,006,620

Rolling Commitments ($USD)

Status
Funded
Reporting Date

04/30/2023

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$1,976

# of Investors

72

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2C

Margin

Low

Capital Intensity

Low

Location

Coto de Caza, California

Business Type

Growth

CERN Corporation, with a valuation of $12 million, is raising funds on StartEngine. The company is developing an effective and non-drug therapeutic treatment for fungal and bacterial vaginosis. The Cern Device uses microbicidal light to mitigate pathogens causing fungal and bacterial vaginosis to promote a healthy microbiome without using drugs. The device is the size of a tampon and can be used at home as and when needed. CERN Corporation has received utility and design patents and is in the pre-revenue and testing stages of development. Gregg A. Klang founded CERN Corporation in February 2016. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000. The campaign proceeds will be used for commercial device development, clinical trials, FDA clearance, and marketing.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-43,711

$-73,704

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$8,964

$8,834

Accounts Receivable

$0

$0

Total Assets

$8,964

$8,834

Short-Term Debt

$37,208

$139,896

Long-Term Debt

$0

$0

Total Liabilities

$37,208

$139,896

Financials as of: 09/15/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
CERN Corporation on StartEngine 2022
Platform: StartEngine
Security Type: Equity - Common
Valuation: $12,006,620
Price per Share: $0.80

Follow company

Follow CERN Corporation on StartEngine 2022

Buy CERN Corporation's Deal Report

Warning: according to the close date for this deal, CERN Corporation may no longer be accepting investments.

CERN Corporation Deal Report

Get KingsCrowd’s comprehensive report on CERN Corporation including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether CERN Corporation is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the CERN Corporation deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge